Shinichi Taira

Title: The Innovative Contributions of Shinichi Taira

Introduction

Shinichi Taira is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental disorders. With a total of 13 patents to his name, Taira's work has the potential to impact the lives of many individuals suffering from various mental health issues.

Latest Patents

One of Taira's latest patents is focused on Piperazine-substituted benzothiophenes for the treatment of mental disorders. This invention provides a heterocyclic compound represented by a specific general formula. The compound boasts a wide treatment spectrum for mental disorders, including central nervous system disorders, while ensuring no side effects and high safety. Another notable patent involves N,N-substituted 3-aminopyrrolidine compounds, which are useful as monoamines reuptake inhibitors. This invention presents a pyrrolidine compound or a salt thereof, which can be utilized to produce a pharmaceutical preparation with a broader therapeutic spectrum and sufficient therapeutic effects after short-term administration.

Career Highlights

Shinichi Taira is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to improving mental health treatments and enhancing patient safety.

Collaborations

Taira has collaborated with notable colleagues, including Nobuaki Ito and Kuninori Tai. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Shinichi Taira's contributions to the field of pharmaceuticals, particularly in mental health treatment, highlight his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to safety and efficacy, making him a significant figure in the realm of medical inventions.